Genetic medicine
Reads, edits or targets genes: DNA sequencing and genetic tests, gene and cell therapies, gene editing and RNA medicines.
Medicine increasingly works at the level of genes. This theme covers DNA sequencing and genetic testing, gene and cell therapies, gene editing and RNA-based medicines.
Companies
113
Core
99
With a moat
27%
Average quality
22
0 wide moat · 31 narrow moat · 82 no moat · Open in screener →
Core The theme describes the company's main business. Partial A meaningful part of the business, but not the main one.
Companies
| Company | Exposure | Industry | Moat | Quality | Market cap |
|---|---|---|---|---|---|
| MRNA Moderna, Inc. | Core | Biotechnology | Narrow | 34 | $90.6B |
| NTRA Natera, Inc. | Core | Life Sciences Tools & Diagnostics | Narrow | 33 | $57.6B |
| ILMN ILLUMINA, INC. | Core | Life Sciences Tools & Diagnostics | Narrow | 59 | $39.5B |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | Core | Biotechnology | Narrow | 54 | $31.2B |
| BNTX BioNTech SE | Core | Biotechnology | Narrow | 43 | $23.5B |
| GH Guardant Health, Inc. | Core | Life Sciences Tools & Diagnostics | Narrow | 25 | $21.2B |
| EXAS EXACT SCIENCES CORP | Core | Biotechnology | Narrow | 39 | $20.0B |
| TEM Tempus AI, Inc. | Core | Life Sciences Tools & Diagnostics | Narrow | 18 | $11.6B |
| QGEN QIAGEN N.V. | Core | Life Sciences Tools & Diagnostics | Narrow | 68 | $9.5B |
| KRYS Krystal Biotech, Inc. | Core | Biotechnology | Narrow | 61 | $9.5B |
| TXG 10x Genomics, Inc. | Core | Life Sciences Tools & Diagnostics | Narrow | 42 | $9.1B |
| TWST Twist Bioscience Corp | Core | Biotechnology | Narrow | 31 | $8.8B |
| CAI Caris Life Sciences, Inc. | Core | Biotechnology | Narrow | 31 | $8.7B |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | Core | Biotechnology | Narrow | 35 | $8.1B |
| IONS IONIS PHARMACEUTICALS INC | Core | Biotechnology | Narrow | 28 | $7.4B |
| GRAL GRAIL, Inc. | Core | Life Sciences Tools & Diagnostics | None | 20 | $5.5B |
| CRSP CRISPR Therapeutics AG | Core | Biotechnology | None | 16 | $5.1B |
| BLLN BillionToOne, Inc. | Core | Life Sciences Tools & Diagnostics | Narrow | 44 | $4.8B |
| ADPT Adaptive Biotechnologies Corp | Core | Life Sciences Tools & Diagnostics | Narrow | 29 | $3.8B |
| VCYT VERACYTE, INC. | Core | Biotechnology | Narrow | 51 | $3.5B |
| CDNA CareDx, Inc. | Core | Biotechnology | Narrow | 34 | $3.5B |
| LEGN Legend Biotech Corp | Core | Biotechnology | Narrow | 28 | $3.5B |
| DYN Dyne Therapeutics, Inc. | Core | Biotechnology | None | 19 | $2.8B |
| BEAM Beam Therapeutics Inc. | Core | Biotechnology | None | 17 | $2.5B |
| PGEN PRECIGEN, INC. | Core | Biotechnology | None | 10 | $2.4B |
| NEO NEOGENOMICS INC | Core | Life Sciences Tools & Diagnostics | None | 27 | $2.1B |
| WGS GeneDx Holdings Corp. | Core | Healthcare Providers & Services | None | 27 | $2.0B |
| BLFS BIOLIFE SOLUTIONS INC | Core | Life Sciences Tools & Diagnostics | Narrow | 47 | $1.9B |
| SRPT Sarepta Therapeutics, Inc. | Core | Biotechnology | Narrow | 35 | $1.9B |
| MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | Core | Life Sciences Tools & Diagnostics | Narrow | 25 | $1.8B |
| QURE uniQure N.V. | Core | Biotechnology | None | 25 | $1.8B |
| PSNL Personalis, Inc. | Core | Life Sciences Tools & Diagnostics | None | 10 | $1.7B |
| NTLA Intellia Therapeutics, Inc. | Core | Biotechnology | None | 22 | $1.6B |
| STOK Stoke Therapeutics, Inc. | Core | Biotechnology | None | 23 | $1.6B |
| TSHA Taysha Gene Therapies, Inc. | Core | Biotechnology | None | 16 | $1.3B |
| WVE Wave Life Sciences Ltd. | Core | Pharmaceuticals | None | 13 | $1.3B |
| CSTL CASTLE BIOSCIENCES INC | Core | Life Sciences Tools & Diagnostics | Narrow | 40 | $983M |
| MGTX MeiraGTx Holdings plc | Core | Biotechnology | None | 14 | $908M |
| FDMT 4D Molecular Therapeutics, Inc. | Core | Biotechnology | None | 18 | $885M |
| PRME Prime Medicine, Inc. | Core | Biotechnology | None | 7 | $698M |
| SANA Sana Biotechnology, Inc. | Core | Biotechnology | None | 13 | $686M |
| SLDB Solid Biosciences Inc. | Core | Biotechnology | None | 19 | $636M |
| IMMX Immix Biopharma, Inc. | Core | Biotechnology | None | 14 | $588M |
| PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Core | Life Sciences Tools & Diagnostics | Narrow | 22 | $572M |
| FLGT Fulgent Genetics, Inc. | Core | Life Sciences Tools & Diagnostics | None | 33 | $554M |
| AUTL Autolus Therapeutics plc | Core | Biotechnology | None | 12 | $551M |
| SOPH SOPHiA GENETICS SA | Core | Health Care Technology | None | 15 | $526M |
| NGNE Neurogene Inc. | Core | Biotechnology | None | 21 | $485M |
| RGNX REGENXBIO Inc. | Core | Biotechnology | None | 19 | $471M |
| ALLO Allogene Therapeutics, Inc. | Core | Biotechnology | None | 11 | $449M |
| MYGN MYRIAD GENETICS INC | Core | Biotechnology | Narrow | 41 | $404M |
| EDIT Editas Medicine, Inc. | Core | Biotechnology | None | 6 | $372M |
| KYTX Kyverna Therapeutics, Inc. | Core | Biotechnology | None | 20 | $362M |
| IRD Opus Genetics, Inc. | Core | Biotechnology | None | 15 | $318M |
| CLLS Cellectis S.A. | Core | Biotechnology | None | 20 | $310M |
| SLN Silence Therapeutics plc | Core | Biotechnology | None | 26 | $300M |
| ARCT Arcturus Therapeutics Holdings Inc. | Core | Biotechnology | Narrow | 26 | $297M |
| BNTC Benitec Biopharma Inc. | Core | Biotechnology | None | 16 | $292M |
| IPSC Century Therapeutics, Inc. | Core | Biotechnology | None | 16 | $270M |
| OCGN Ocugen, Inc. | Core | Biotechnology | None | 10 | $268M |
| ABEO ABEONA THERAPEUTICS INC. | Core | Biotechnology | None | 24 | $253M |
| CABA Cabaletta Bio, Inc. | Core | Biotechnology | None | 14 | $253M |
| RCKT ROCKET PHARMACEUTICALS, INC. | Core | Biotechnology | None | 15 | $246M |
| LXEO Lexeo Therapeutics, Inc. | Core | Biotechnology | None | 20 | $227M |
| FATE FATE THERAPEUTICS INC | Core | Biotechnology | None | 15 | $224M |
| CAMP Camp4 Therapeutics Corp | Core | Biotechnology | None | 14 | $197M |
| PEPG PepGen Inc. | Core | Biotechnology | None | 20 | $188M |
| RNAC Cartesian Therapeutics, Inc. | Core | Biotechnology | None | 16 | $184M |
| DTIL PRECISION BIOSCIENCES INC | Core | Biotechnology | None | 17 | $171M |
| PRQR ProQR Therapeutics N.V. | Core | Biotechnology | None | 15 | $160M |
| IDXG INTERPACE BIOSCIENCES, INC. | Core | Life Sciences Tools & Diagnostics | None | 43 | $143M |
| MXCT MAXCYTE, INC. | Core | Life Sciences Tools & Diagnostics | None | 21 | $134M |
| KRRO Korro Bio, Inc. | Core | Biotechnology | None | 13 | $131M |
| VYGR Voyager Therapeutics, Inc. | Core | Biotechnology | None | 14 | $127M |
| NKTX Nkarta, Inc. | Core | Biotechnology | None | 24 | $125M |
| INO INOVIO PHARMACEUTICALS, INC. | Core | Biotechnology | None | 6 | $104M |
| IMDX Insight Molecular Diagnostics Inc. | Core | Life Sciences Tools & Diagnostics | None | 16 | $96M |
| TNYA Tenaya Therapeutics, Inc. | Core | Biotechnology | None | 14 | $85M |
| LUCD Lucid Diagnostics Inc. | Core | Life Sciences Tools & Diagnostics | None | 14 | $77M |
| CRBU Caribou Biosciences, Inc. | Core | Biotechnology | None | 16 | $50M |
| ACET Adicet Bio, Inc. | Core | Biotechnology | None | 15 | $43M |
| MGX Metagenomi Therapeutics, Inc. | Core | Biotechnology | None | 11 | $31M |
| RNAZ Transcode Therapeutics, Inc. | Core | Biotechnology | None | 14 | $28M |
| BNR Burning Rock Biotech Ltd | Core | Biotechnology | None | 24 | $26M |
| TCRX TScan Therapeutics, Inc. | Core | Biotechnology | None | 13 | $15M |
| BNGO Bionano Genomics, Inc. | Core | Life Sciences Tools & Diagnostics | None | 20 | $14M |
| PASG Passage BIO, Inc. | Core | Biotechnology | None | 8 | $12M |
| PHIO Phio Pharmaceuticals Corp. | Core | Biotechnology | None | 13 | $10M |
| SNTI Senti Biosciences, Inc. | Core | Biotechnology | None | 4 | $7M |
| CDIO Cardio Diagnostics Holdings, Inc. | Core | Biotechnology | None | 13 | $5M |
| ERNA Ernexa Therapeutics Inc. | Core | Biotechnology | None | 9 | $3M |
| MBIO MUSTANG BIO, INC. | Core | Biotechnology | None | 14 | $3M |
| VNRX VOLITIONRX LTD | Core | Life Sciences Tools & Diagnostics | None | 6 | $2M |
| GNPX Genprex, Inc. | Core | Biotechnology | None | 14 | $2M |
| BPTH BIO-PATH HOLDINGS, INC. | Core | Biotechnology | None | 7 | $2M |
| MDXH MDxHealth SA | Core | Life Sciences Tools & Diagnostics | None | 16 | $1M |
| ENGN enGene Therapeutics Inc. | Core | Biotechnology | None | 20 | — |
| GNTA Genenta Science S.p.A. | Core | Biotechnology | None | 20 | — |
| SLXN Silexion Therapeutics Corp | Core | Biotechnology | None | 13 | — |
| AZTA Azenta, Inc. | Partial | Life Sciences Tools & Diagnostics | Narrow | 39 | $1.5B |
| VOR Vor Biopharma Inc. | Partial | Biotechnology | None | 14 | $1.1B |
| CYRX Cryoport, Inc. | Partial | Life Sciences Tools & Diagnostics | None | 30 | $861M |
| MLAB MESA LABORATORIES INC /CO/ | Partial | Life Sciences Tools & Diagnostics | Narrow | 43 | $690M |
| CLPT ClearPoint Neuro, Inc. | Partial | Medical Devices & Supplies | None | 22 | $279M |
| OSUR ORASURE TECHNOLOGIES INC | Partial | Medical Devices & Supplies | Narrow | 35 | $255M |
| LAB STANDARD BIOTOOLS INC. | Partial | Life Sciences Tools & Diagnostics | None | 18 | $251M |
| GUTS FRACTYL HEALTH, INC. | Partial | Medical Devices & Supplies | None | 16 | $223M |
| CDXS CODEXIS, INC. | Partial | Life Sciences Tools & Diagnostics | Narrow | 29 | $146M |
| ANIX Anixa Biosciences Inc | Partial | Biotechnology | None | 20 | $91M |
| IMNN Imunon, Inc. | Partial | Biotechnology | None | 12 | $6M |
| BNBX BNB PLUS CORP. | Partial | Life Sciences Tools & Diagnostics | None | 14 | $1M |
| BGLC BioNexus Gene Lab Corp | Partial | Distributors & Equipment Rental | None | 19 | — |
| IMTX Immatics N.V. | Partial | Biotechnology | None | 17 | — |
113 companies.
Price versus fair value for every company is in the screener.